SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001359824-10-000006
Filing Date
2010-02-26
Accepted
2010-02-26 16:18:25
Documents
5

Document Format Files

Seq Description Document Type Size
1 DUSA PHARMACEUTICALS, INC SCHEDULE 13D 2 26 10 FILING schedule13d.htm SC 13D 203192
2 JOINT FILING AGREEMENT exhibit1.htm EX-1.HTM 33253
3 NOMINATION LETTER exhibit2.htm EX-2.HTM 48922
4 POWER OF ATTORNEY DATED JANUARY 26, 2010 exhibit3.htm EX-3.HTM 4058
5 POWER OF ATTORNEY DATED JANUARY 26, 2010 exhibit4.htm EX-4.HTM 4106
  Complete submission text file 0001359824-10-000006.txt   295493
Mailing Address 25 UPTON DRIVE WILMINGTON MA 01887
Business Address 25 UPTON DRIVE WILMINGTON MA 01887 9786577500
DUSA PHARMACEUTICALS INC (Subject) CIK: 0000879993 (see all company filings)

IRS No.: 223103129 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-42248 | Film No.: 10639577
SIC: 2834 Pharmaceutical Preparations

Mailing Address 300 CRESCENT COURT SUITE 1111 DALLAS TX 75201
Business Address 300 CRESCENT COURT SUITE 1111 DALLAS TX 75201 214-756-6073
SRB Management, L.P. (Filed by) CIK: 0001346543 (see all company filings)

IRS No.: 000000000 | State of Incorp.: TX | Fiscal Year End: 1231
Type: SC 13D